Redeye saw sales that were in line with our expectations. The positive Carbonhand development helped sales to recover from the weak previous quarter. The cost-cutting is having an effect, and even slightly faster than expected. Carbonhand in Europe has a positive momentum, and we expect that there will be orders from the US soon. The report, in line with our lowered expectations, makes us make some small changes.